Wellington Management Group’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Wellington Management Group’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-29,320	Closed	-$866K	–	2267
2021 Q4	$866K	Sell	29,320 -15,002	-34%	-$613K	﹤0.01%	1827
2021 Q3	$2.29M	Sell	44,322 -89,141	-67%	-$6.34M	﹤0.01%	1662
2021 Q2	$16.3M	Sell	133,463 -14,343	-10%	-$2.23M	﹤0.01%	1139
2021 Q1	$27.3M	Sell	147,806 -8,979	-6%	-$2.13M	﹤0.01%	993
2020 Q4	$42.9M	Buy	156,785 +23,250	+17%	+$5.84M	0.01%	810
2020 Q3	$31.3M	Buy	+133,535	New	+$33.5M	0.01%	833

Other funds holding FRLN

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wellington Management Group's FRLN Position: Q1 2022 in Review

Wellington Management Group sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2022, closing a stake of 29,320 shares — an estimated $866K sold.

Wellington Management Group first reported a position in FRLN in Q3 2020 and held it in 6 quarters. The position peaked at $42.9M in Q4 2020. 19 funds tracked by Wall St. Rank hold FRLN as of Q1 2022.

Wellington Management Group reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Wellington Management Group sold 29,320 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2022, an estimated $866K.
Wellington Management Group first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 6 quarters.
Wellington Management Group's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $42.9M in Q4 2020.
19 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2022.

Based on Wellington Management Group's 13F filing for Q1 2022, filed 16 May 2022.